BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis

The world is facing the rising emergency of SARS-CoV-2. The outbreak of COVID-19 has caused a global public health and economic crisis. Recent epidemiological studies have shown that a possible association of BCG vaccination program with decreased COVID-19-related risks, suggesting that BCG may prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Yusuke, Sato, Ryo, Ikeda, Tokunori, Sakagami, Takuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440160/
https://www.ncbi.nlm.nih.gov/pubmed/32863070
http://dx.doi.org/10.1016/j.vaccine.2020.08.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440160/
https://www.ncbi.nlm.nih.gov/pubmed/32863070
http://dx.doi.org/10.1016/j.vaccine.2020.08.045

Ejemplares similares